openPR Logo
Press release

Preimplantation Genetic Testing Market-Size Report 2022

Preimplantation Genetic Testing Market

Preimplantation Genetic Testing Market

Preimplantation Genetic Testing Market by type 2017-2022 by new Service spreads across 204 pages profiling 17 companies and supported with 85 tables and 42 figures available at ReportsnReports.com

Get sample copy for information professional insights@ http://www.reportsnreports.com/contacts/requestsample.aspx?name=1128201

“Preimplantation Genetic Testing Market projected to grow at a CAGR of 10.0%”
The global preimplantation genetic testing market is expected to reach USD 541.8 million by 2022 from USD 336.4million in 2017, at a CAGR of 10.0%. Growing rate of infertility across the globe, increasing public-private investments in the field of preimplantation genetic testing, rising number of fertility clinics worldwide, technological advancements in the field of genetic analysis, and high risk of chromosomal abnormalities in the fetus with increasing maternal age are some of the key factors driving the growth of this market. However, the high procedural cost associated with preimplantation genetic testing and unsupportive government regulations are the factors restraining the growth of this market

“Next-generation Sequencing is expected to grow at the highest CAGR during 2017 to 2022”
By technology, the preimplantation genetic testing market covers next-generation sequencing (NGS), polymerase chain reaction (PCR), fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), and single-nucleotide polymorphism (SNP). The NGS segment is expected to grow at the highest CAGR during 2017 to 2022, owing to benefits like reduced cost, better ability to detect an embryo with differing results (mosaicism), enhanced detection of structural abnormalities such as chromosomes with missing or duplicate segments, and reduction in human errors due to increased automation.

Access this more information@ http://www.reportsnreports.com/contacts/discount.aspx?name=1128201

“The maternity centers & fertility clinics to dominate the global preimplantation genetic testing market during the forecast period”
On the basis of end users, the preimplantation genetic testing market is segmented into maternity centers & fertility clinics; hospitals, diagnostic labs, and service providers; and research laboratories & academic institutes. The maternity centers & fertility clinics segment accounted for the largest share of the global preimplantation genetic testing market in 2016 owing to the high success rate of treatments at fertility centers.

Preimplantation Genetic Diagnosis and Screening Market, By Procedure Type
• Introduction
• Preimplantation Genetic Screening
• Preimplantation Genetic Diagnosis

Preimplantation Genetic Diagnosis and Screening Market, By Technology
• Introduction
• Next-Generation Sequencing
• Polymerase Chain Reaction
• Fluorescence in Situ Hybridization
• Comparative Genomic Hybridization
• Single-Nucleotide Polymorphis

Please fill ALL required information to help us serve you better: http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=1128201

14 Company Profiles

(Overview, Products and Services, Financials, Strategy & Development)*
14.1 Top Product Manufacturers
14.1.1 Illumina, Inc.
14.1.2 Thermo Fisher Scientific Inc.
14.1.3 Agilent Technologies, Inc.
14.1.4 Perkinelmer, Inc.
14.1.5 Coopersurgical, Inc. (A Subsidiary of the Cooper Companies, Inc.)
14.1.6 ABBott Laboratories
14.1.7 Natera, Inc.
14.1.8 Rubicon Genomics (A Subsidiary of Takara Bio Usa Holdings, Inc.)
14.1.9 Oxford Gene Technology
14.1.10 Yikon Genomics
14.1.11 Scigene
14.2 Top Service Provider Companies
14.2.1 Beijing Genomics Institute
14.2.2 Good Start Genetics, Inc.
14.2.3 Invicta Genetics
14.2.4 Combimatrix Corporation
14.2.5 Genea Limited
14.2.6 Progenesis

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

About Company:
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

Contact Us
Corporate Headquarters
2nd floor, metropole,
Next to inox theatre,
Bund garden road,
Pune-411001.
+ 1 888 391 5441

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Preimplantation Genetic Testing Market-Size Report 2022 here

News-ID: 668403 • Views: 172

More Releases for Gene

Gene Therapy Market, by Gene Therapy Type Germline Gene Therapy and Somatic Gene …
Genes are composed of deoxyribonucleic acid (DNA), which contains essential information for producing proteins that are crucial for the optimal functioning of the body. Genetic disorder is the result of gene mutations in which proteins are made incorrectly. Gene therapy is intended to introduce healthy gene into damaged cells to counteract for abnormal genes or to make a protein of interest. Mutated gene causes missing of the important protein, with
Hemophilia Gene Therapy - A Pipeline Analysis Report
"The Report Hemophilia Gene Therapy - A Pipeline Analysis Report provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Hemophilia Gene Therapy: An insight Hemophilia is an inherited bleeding disorder. The gene responsible for hemophilia is present on the X chromosome and is inherited in a recessive manner. Hemophilia A, also called as factor VIII (FVIII) deficiency or classic hemophilia, is caused by missing
Gene Synthesis Market Size 2017-2022 OriGene, Gene Oracle, Genescript
e Global Gene Synthesis Market Research Report 2016 is a professional and in-depth study on the current state of the Gene Synthesis market. Annual estimates and forecasts are provided for the period 2017 through 2022. Also, a six-year historic analysis is provided for these markets. The Global market for Gene Synthesis is expected to reach about 410 million USD by 2022 from 200 million USD in 2017, registering a compounded
Gene Therapy Drug Pipeline Analysis
“Gene Therapy Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drugs being developed for the treatment of multiple disease based upon Gene Therapy. Research report covers all the ongoing drug development in various development phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Country of Development and detailed analysis on the development process. Insight
Cancer Gene Therapy Market Analysis
The gene therapy market has undergone series of transformation from the initial days of research to current clinical development of drugs for treatment of multiple diseases. The initial studies of gene therapy were conducted mostly on monogenetic diseases, but the focus of the researchers rapidly shifted towards the cancer. The increasing popularity of cancer therapeutics as a major interest for gene therapy applications led to it accounting for a dominant
Global Gene Synthesis Market Research Report 2017
Global Gene Synthesis Market Research Report 2016 is a professional and in-depth study on the current state of the Gene Synthesis market. Annual estimates and forecasts are provided for the period 2017 through 2022. Also, a six-year historic analysis is provided for these markets. The Global market for Gene Synthesis is expected to reach about 410 million USD by 2022 from 200 million USD in 2017, registering a compounded annual